Is VERU INC. (VERU) Halal?
Shariah Screening — 5 Standards
Based on financial data from September 2025
| Standard | Debt Ratio | Cash Ratio | Receivables | Income | Status |
|---|---|---|---|---|---|
| AAOIFI | 7.9% / 30% | 46.2% / 30% | 0.0% / 30% | N/A | ✗ NOT HALAL |
| DJIM | 7.9% / 33% | 46.2% / 33% | 0.0% / 33% | N/A | ✗ NOT HALAL |
| MSCI | 10.4% / 33% | 61.4% / 33% | 0.0% / 33% | N/A | ✗ NOT HALAL |
| S&P | 7.9% / 33% | 46.2% / 33% | 0.0% / 33% | N/A | ✗ NOT HALAL |
| FTSE | 10.4% / 33% | 61.4% / 33% | 0.0% / 50% | N/A | ✗ NOT HALAL |
Financial Highlights
Profitability
| Gross Margin | 0.0% | |
| Operating Margin | 0.0% | |
| Net Margin | 0.0% | |
| Return on Equity (ROE) | -60.2% | |
| Return on Assets (ROA) | -42.9% |
Cash Flow & Balance Sheet
| Operating Cash Flow | -$30M |
| Free Cash Flow | -$30M |
| Total Debt | $3M |
| Debt-to-Equity | 8.0 |
| Current Ratio | 5.2 |
| Total Assets | $30M |
Price & Trading
| Last Close | $2.23 |
| 50-Day MA | $2.46 |
| 200-Day MA | $3.46 |
| Avg Volume | 103K |
| Beta | -1.4 |
|
52-Week Range
$2.06
| |
About VERU INC. (VERU)
Veru Inc., a late clinical stage biopharmaceutical company, focuses on developing medicines for treatment of metabolic diseases, oncology, and viral-induced acute respiratory distress syndrome (ARDS) in Florida and internationally. It provides FC2 female condom for the dual protection against unplanned pregnancy and the transmission of sexually transmitted infections. The company develops enobosarm, a selective androgen receptor modulator for treatment of augment fat loss and to prevent muscle loss in sarcopenic obese and overweight elderly patients; Enobosarm, an oral selective androgen receptor modulator for the treatment of AR+ ER+ HER2- metastatic breast cancer; and sabizabulin, a microtubule disruptor for the treatment of hospitalized patients with viral lung infection at high risk for viral induced ARDS and death. The company was formerly known as The Female Health Company and changed its name to Veru Inc. in July 2017. Veru Inc. was incorporated in 1971 and is headquartered in Miami, Florida.
Related Halal Stocks in Healthcare
Frequently Asked Questions
Is VERU INC. (VERU) halal to invest in?
Based on our screening using AAOIFI Standard 21 (the strictest methodology), VERU INC. is Not Halal. The company fails one or more screening criteria. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.
What is VERU INC.'s debt ratio?
VERU INC.'s debt ratio is 7.9% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 10.4%.
What are VERU INC.'s key financial metrics?
VERU INC. has a market capitalization of $34M. Return on equity stands at -60.2%.
How often is the screening data updated?
Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.
Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.